Showing results (51-60 of 242) with videos related to

Sort By:
Pageof 25
Clinical Colorectal Cancer|January 24, 2007
Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil countMichael Michael, David Goldstein, Stephen J Clarke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 17, 2024
Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxisRebecca Symons, Fiona Heath, Jennifer Duggan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2026
Informative censoring in maintenance therapy trials for advanced ovarian cancer: An empirical assessment of its impact on treatment benefitRachel Woodford, Sally Lord, Annelise Decaria, et al.
Clinical Colorectal Cancer|August 8, 2007
Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacyStephen Clarke, David Goldstein, Paul Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2021
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reportingKatherine E Francis, Val Gebski, Sarah J Lord, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 14, 2016
The patient-reported outcome content of international ovarian cancer randomised controlled trial protocolsRebecca Mercieca-Bebber, Michael Friedlander, Peey-Sei Kok, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practiceRebecca Mercieca-Bebber, Michael Friedlander, Melanie Calvert, et al.
The Journal of Sexual Medicine|May 3, 2013
The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancerIlona Juraskova, Sherin Jarvis, Kelly Mok, et al.
The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2018
Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancerVanessa L Beesley, David D Smith, Christina M Nagle, et al.
Pageof 25